OUR PRODUCTS

MOBILE APPS

GENERAL INFO

BLTE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Belite Bio (BLTE) Earnings Date & Reports

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BLTE is expected to report earnings to rise 43.70% to -38 cents per share on August 11

Q2'25

Est.

$-0.39

Q1'25

Beat

by $0.10

Q4'24

Est.

$-0.32

Q3'24

Beat

by $0.01

Q2'24

Missed

by $0.05

The last earnings report on May 14 showed earnings per share of -27 cents, beating the estimate of -37 cents. With 8.68K shares outstanding, the current market capitalization sits at 2.27B.

View a ticker or compare two or three

Compare

BLTE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BLTE
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BLTE showed earnings on May 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

12750 High Bluff Drive

Phone

+1 858 246-6240

Employees

Web

https://www.belitebio.com